Related Experiment Video
Updated: May 14, 2026

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
[Oncological intensive care: 2011 year's review]
J P Sculier1, T Berghmans, A P Meert
1Service des Soins Intensifs et Urgences Oncologiques, Institut Jules Bordet, Centre des Tumeurs de l'ULB, Bruxelles. sculier@bordet.be
This review covers 2011 literature on intensive care and emergency medicine for cancer patients. It highlights advances in managing oncologic emergencies, chemotherapy toxicities, and related complications.
Area of Science:
- Oncology
- Intensive Care Medicine
- Emergency Medicine
Context:
- Literature review of publications from 2011.
- Focus on intensive care and emergency settings.
- Specialized in oncology patient management.
Purpose:
- To synthesize recent advancements in intensive care and emergency medicine for oncology.
- To provide an overview of critical care issues in cancer patients.
Summary:
- Discusses prognosis, resuscitation techniques, and oncologic emergencies.
- Covers serious toxicities from chemotherapy and targeted therapies.
- Addresses complicated aplastic anemia, bisphosphonate toxicity, and respiratory, pulmonary embolism, and neurological complications.
Impact:
- Informs clinicians on the latest evidence for managing complex cancer emergencies.
- Aids in optimizing critical care strategies for cancer patients.
- Highlights key areas for future research in oncologic critical care.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury V: Interprofessional Care
Interdisciplinary Care: The Health Care Team-II
Physical Therapist
A physical therapist (PT) aims to restore function or prevent additional impairment in a patient following an injury or disease. Massage, heat, cold, water, sonar waves, exercises, and electrical stimulation are some treatments used by PTs to treat...
Standards of Care II